Fonte: Scientific Reports. Unidades: FOB, FORP
Assuntos: PERIODONTITE, IMPLANTES DENTÁRIOS, OSTEONECROSE, MANDÍBULA
ABNT
SOUZA, Eduardo Quintão Manhanini et al. Peri-implantitis increases the risk of medication-related osteonecrosis of the jaws associated with osseointegrated implants in rats treated with zoledronate. Scientific Reports, v. 14, n. Ja 2024, 2024Tradução . . Disponível em: https://doi.org/10.1038/s41598-023-49647-4. Acesso em: 08 out. 2025.APA
Souza, E. Q. M., Toro, L. F., Ganzaroli, V. F., Freire, J. de O. A., Matsumoto, M. A., Casatti, C. A., et al. (2024). Peri-implantitis increases the risk of medication-related osteonecrosis of the jaws associated with osseointegrated implants in rats treated with zoledronate. Scientific Reports, 14( Ja 2024). doi:10.1038/s41598-023-49647-4NLM
Souza EQM, Toro LF, Ganzaroli VF, Freire J de OA, Matsumoto MA, Casatti CA, Cintra LTA, Buchaim RL, Issa JPM, Garcia VG, Theodoro LH, Ervolino E. Peri-implantitis increases the risk of medication-related osteonecrosis of the jaws associated with osseointegrated implants in rats treated with zoledronate [Internet]. Scientific Reports. 2024 ; 14( Ja 2024):[citado 2025 out. 08 ] Available from: https://doi.org/10.1038/s41598-023-49647-4Vancouver
Souza EQM, Toro LF, Ganzaroli VF, Freire J de OA, Matsumoto MA, Casatti CA, Cintra LTA, Buchaim RL, Issa JPM, Garcia VG, Theodoro LH, Ervolino E. Peri-implantitis increases the risk of medication-related osteonecrosis of the jaws associated with osseointegrated implants in rats treated with zoledronate [Internet]. Scientific Reports. 2024 ; 14( Ja 2024):[citado 2025 out. 08 ] Available from: https://doi.org/10.1038/s41598-023-49647-4